These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32130721)

  • 1. Platelet factor 4 inhibits ADAMTS13 activity and regulates the multimeric distribution of von Willebrand factor.
    Nazy I; Elliott TD; Arnold DM
    Br J Haematol; 2020 Aug; 190(4):594-598. PubMed ID: 32130721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura.
    Budde U; Schneppenheim R
    Hamostaseologie; 2014; 34(3):215-25. PubMed ID: 25010251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. von Willebrand factor, von Willebrand factor-cleaving protease, and shear stress.
    Perutelli P; Molinari AC
    Cardiovasc Hematol Agents Med Chem; 2007 Oct; 5(4):305-10. PubMed ID: 17979694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet reactive conformation and multimeric pattern of von Willebrand factor in acquired thrombotic thrombocytopenic purpura during acute disease and remission.
    Lotta LA; Lombardi R; Mariani M; Lancellotti S; De Cristofaro R; Hollestelle MJ; Canciani MT; Mannucci PM; Peyvandi F
    J Thromb Haemost; 2011 Sep; 9(9):1744-51. PubMed ID: 21726405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Von Willebrand factor and ADAMTS13 balancing primary haemostasis].
    Schneppenheim R; Budde U
    Hamostaseologie; 2011 Nov; 31(4):275-80. PubMed ID: 21792464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
    Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
    Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand factor-cleaving protease activity and proteolysis of von Willebrand factor in bone marrow transplant-associated thrombotic microangiopathy.
    Arai S; Allan C; Streiff M; Hutchins GM; Vogelsang GB; Tsai HM
    Hematol J; 2001; 2(5):292-9. PubMed ID: 11920264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The active conformation of von Willebrand factor in patients with thrombotic thrombocytopenic purpura in remission.
    Groot E; Fijnheer R; Sebastian SA; de Groot PG; Lenting PJ
    J Thromb Haemost; 2009 Jun; 7(6):962-9. PubMed ID: 19548905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Link between von Willebrand factor multimers, relapses and coronary microcirculation in patients with thrombotic thrombocytopenic purpura in remission.
    Di Pasquale I; Budde U; Tona F; Bertomoro A; Lombardi AM; Famoso G; Bertozzi I; Dittmer R; Schneppenheim S; Fabris F
    Thromb Res; 2019 Jan; 173():42-47. PubMed ID: 30471507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura.
    Manea M; Karpman D
    Pediatr Nephrol; 2009 Mar; 24(3):447-58. PubMed ID: 18807073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of von Willebrand factor high-molecular-weight multimers at acute phase is associated with detectable anti-ADAMTS13 IgG and neurological symptoms in acquired thrombotic thrombocytopenic purpura.
    Béranger N; Benghezal S; Savigny S; Capdenat S; Joly BS; Coppo P; Stepanian A; Veyradier A
    Thromb Res; 2019 Sep; 181():29-35. PubMed ID: 31330376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shedding Light on the Possible Link between ADAMTS13 and Vaccine-Induced Thrombotic Thrombocytopenia.
    Szóstek-Mioduchowska A; Kordowitzki P
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma ADAMTS13, von Willebrand Factor (VWF), and VWF Propeptide Profiles in Patients With Connective Tissue Diseases and Antiphospholipid Syndrome.
    Habe K; Wada H; Matsumoto T; Ohishi K; Ikejiri M; Tsuda K; Kondo M; Kamimoto Y; Ikeda T; Katayama N; Mizutani H
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):622-630. PubMed ID: 26759371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombosis and von Willebrand Factor.
    Shahidi M
    Adv Exp Med Biol; 2017; 906():285-306. PubMed ID: 27628010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Von Willebrand factor: another janus-faced hemostasis protein.
    Franchini M; Mannucci PM
    Semin Thromb Hemost; 2008 Oct; 34(7):663-9. PubMed ID: 19085767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-free shear flow assay facilitates analysis of shear-dependent functions of VWF and ADAMTS13.
    Kraus E; Kraus K; Obser T; Oyen F; Klemm U; Schneppenheim R; Brehm MA
    Thromb Res; 2014 Dec; 134(6):1285-91. PubMed ID: 25201004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential therapeutic benefit of targeting ADAMTS13 activity.
    Eerenberg ES; Levi M
    Semin Thromb Hemost; 2014 Feb; 40(1):28-33. PubMed ID: 24338607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between ADAMTS13 and von Willebrand factor in inherited and acquired thrombotic microangiopathies.
    Soejima K; Nakagaki T
    Semin Hematol; 2005 Jan; 42(1):56-62. PubMed ID: 15662617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor.
    Crawley JT; de Groot R; Xiang Y; Luken BM; Lane DA
    Blood; 2011 Sep; 118(12):3212-21. PubMed ID: 21715306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.